NDTVCenter·
Cipla's Pune Godown Loses Drug Licence Over 'Misbranding, Storage Violations'
A major reason for the action was the misbranding of 'Reactin Plus', a Schedule-H drug that cannot be sold over the counter.
Read at NDTV →
US · 2 sources covering this
Cipla's Pune Godown Loses Drug Licence Over 'Misbranding, Storage Violations'
A major reason for the action was the misbranding of 'Reactin Plus', a Schedule-H drug that cannot be sold over the counter.
Coverage spectrum
0 L · 2 C · 0 R
How 2 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/d4e921a621166638903eecfad72b96db3b93dd6f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cipla's Pune Godown Loses Drug Licence Over 'Misbranding, Storage Violations'"></iframe>
